andexanet alfa

Even amid the thick of earnings season, biotech stocks sway to the din produced by catalytic events, which include PDUFA action dates. Here's a rundown on the PDUFA dates scheduled for the month of May. 1. Will Second Time Be Charm For Portola? Company: Portola Pharmaceuticals Inc (...

Credit Suisse has downgraded Portola Pharmaceuticals Inc (NASDAQ: PTLA) to Neutral from Outperform on balanced risk/reward following the recovery in shares since late March. The brokerage also cut its price target by $3 to $30 on "more conservative assumptions around the uptake of Andexanet Alfa...